World Wide Trends - Pagina 13 di 16

12 giugno 2023

North America Is Dominating Endoscope Industry

The endoscope market is experiencing growth, according to P&S Intelligence. In the coming few years, North America is projected to hold the largest market share. This can be credited to the rising elderly populace, increasing occurrence of chronic illnesses, and growing count of hospitals in the continent. Also, the existence of key industry players, continuous technological improvements, and refining healthcare facilities will ease market development.

The rising cases of chronic diseases, including respiratory illnesses, and cardiovascular illnesses will boost the need for progressive endoscopy equipment in the near future. The Heart Disease and Stroke Statistics 2018 statement of the American Heart Association (AHA) stated that the U.S. witnessed 836,546 CVD demises, which was reported for about one in every three demises in the nation.

Also, as per the 2017 estimations of the Canadian Cancer Society, cancer was the major reason of death in Canada, and closely one in four people expired from it, which amounted to 30.2% of the demises in the nation.

Other major factors of demise in Canada are cardiovascular disease, accidents, and chronic lesser respiratory syndromes. The growing cases of such conditions are causing an increase in the volume of endoscopy events, therefore driving the endoscope industry development.

North America is the biggest user of endoscopes and is projected to advance with a market share of more than 47.7% in the coming few years. This can be ascribed to the quick technological growth, presence of key market companies, huge count of hospitals, better-quality healthcare infrastructure, high occurrence of chronic diseases, and a huge population of aging people.

In North America, the U.S. dominated the endoscope market because of the growing cases of gastrointestinal and respiratory illnesses, the rising elderly populace, and the rising count of hospitals.

Hence, the rising cases of chronic diseases, including respiratory illnesses, and cardiovascular illnesses are the major factors contributing to the growth of the endoscope market.

12 giugno 2023

Medical Robotics Systems Industry is Dominated by North America

The medical robotic systems market will grow at a rate of 20.2% in the years to come, to reach USD 56.5 billion by 2030.

The increasing requirement for robotic processes, increasing elderly population leading to the growing for elderly care, snowballing usage of automated pharmacy systems, and mounting healthcare and medical robotics spending are the main factors powering the industry.

Surgical robotic systems dominated the industry. This category will progress with fastest in the years to come, to be the largest.

The advance of the category is mainly credited to the growing requirement for minimally invasive robotic surgeries, which need lesser time and effort, as opposed to manual surgeries.

The medical robotic systems market in North America will be dominant in the years to come, evolving with the highest CAGR, as stated by P&S Intelligence.

The growth in the North America is because of the occurrence of giant players, well-structured healthcare, increasing requirement for minimally invasive surgeries, and backing by the administration for medical robots.

Also, market players are aggressively involved in strategic expansions and absorbed on raising funds, for establishing strong grounds in the sector.

The increasing use of automated pharmacy systems powers the growth of the market. It decreases the time for locating the agreed drugs in dispensaries and lets pharmacists and technicians to have extra time with the patients.

Its additional advantages contain the freeing up of space in the pharmacy, decreased dispensing errors, and lesser patient waiting time. As a result of such recompences, pharmacies are quickly accepting these systems, hence improving the industry growth.

The growing elderly people, all over the world has a lot to do with the continuously growing demand for medical robotics systems.

8 giugno 2023

Defibrillator Industry Is Dominated by North America

As per a report by P&S Intelligence, the defibrillator market will advance at a rate of 7.2%, to reach USD 20,281.6 million, by 2030.

Key factors driving the growth of the industry are the rising number of strategic developments among key players, quick advancements in defibrillator technology, and the increasing incidence of cardiac diseases.

Based on type, the ICDs category accounted for the larger share of the industry in recent years, and it is likely to dominate the industry throughout this decade. This is credited to the growing emphasis of players on developing technologically advanced ICDs and rising product launches.

In the past few years, the adult patient type category accounted for the larger share of the industry, and it will demonstrate faster growth in the years to come. This is because the incidence of sudden cardiac arrest in the adult population is significantly higher than in the elderly population.

A key trend observed in the defibrillator industry is the deployment of automated external defibrillators in public spaces, for instance, airports, leisure centers, shopping centers, railway stations, malls, and colleges & schools.

Over the past few years, numerous developments have been made in the defibrillation technology. For instance, ZOLL Medical Corporation developed a lightweight defibrillator LifeVest that can be worn easily by patients at risk of SCA. This device monitors the heart rhythm of the patient regularly and when it detects any abnormality it produces a shock for restoring the normal heart rhythm.

In the past few years, the players in the industry have been involved in strategic developments, for instance, product launches, to maintain a competitive edge.

It is because of the increasing prevalence of cardiac diseases, the rising elderly population, and advancement in defibrillation technology, the growth of the defibrillator industry will continue to grow in the years to come.

8 giugno 2023

Radiotherapy Industry Generated the Highest Revenue in North America

The radiotherapy market will advance at a rate of 8.4% in the years to come to reach USD 17,194.4 million by 2030. The growing frequency of cancer and increasing acceptance of advanced treatment procedures are the key factors supporting the growth of the market.

External-Beam Equipment will observe the fastest growth in the years to come. In this radiation therapy high-energy X-ray radiation is transported to tumors within the body of the patient by a machine outside it.

Hospitals generated the highest revenue in the recent past, as stated by a market expert at P&S Intelligence. This is because most of the radiotherapy processes are done at hospitals, in the supervision of trained healthcare specialists, as a result of their intricacy.

APAC radiotherapy market will grow the fastest in the years to come. The main factors supporting this industry growth include the increasing burden of cancer, inciting investments by public and private organizations, and improving healthcare infra.

The rising burden of continuing diseases is disturbing LMICs, in addition to high-income countries. For example, cancer is one of the most-dominant chronic illnesses globally.

As per the American Institute of Cancer Research, by 2030, the count of new cancer cases will reach about 25 million. Most of these cases will be recorded in LMICs, for example China and India.

Tech progressions in treatment protocols have powered the requirement of the demand for automated products, which can be combined into clinical practice systems for reducing the time and surge the efficiency of treatments. As a result of these expansions, the market will have a positive effect in the future. With tech progressions, there has been a widespread emphasis on the enhancement of patient care.

Moreover, the obtainability of automated, more-efficient, and innovative clinical tools in radiation therapy and arrival of SBRT, IMRT, IGRT, VMAT, SRS, proton therapy, and brachytherapy, are contributing significantly to the growth of the industry for radiotherapy equipment.

Increasing healthcare expenditure all over the world, has a lot to do with the increasing requirement for radiotherapy, in the years to come.

7 giugno 2023

Professional Aesthetic Lasers Was Dominated by North America

As per a market research report by P&S Intelligence, professional aesthetic lasers market will grow at a rate of 10.3% in the years to come, to reach USD 3,387.4 million by 2030.

This growth has a lot to do with the growing consciousness through conferences and seminars, increasing elderly population, increasing income, budding medical tourism sector, growing volume of aesthetic procedures, tech progression, and surging consciousness pertaining to the safety and advantages of laser-based aesthetic devices.

The skin rejuvenation category had the largest share, and it will retain its position in the years to come. This is because of the increasing incidence of some unwanted changes, for example, scars, fine lines, wrinkles, rough texture, enlarged pores, and dull tone, which become obvious on the human face with age.

North America dominated the professional aesthetic lasers market in the recent past. This has a lot to do with the rising healthcare spending, occurrence of more than a few market players, obtainability of cutting-edge aesthetic laser systems, and increasing consciousness about aesthetic treatments.

Worldwide, more than a few exhibitions, conferences, and seminars are being organized for raising consciousness amongst plastic surgeons, students and general public pertaining to the progressions in anti-aging treatments. More than a few market players are, consequently, aggressively taking part in these exhibitions and events to showcase and introduce their offerings.

The loss of fibrous tissue and decrease in skin stem cells, leading to the incidence of wrinkles, pigmentary alteration, dryness, and sagging, accompanied by the increase in elderly population.

As per UNDESA, the population of people aged 65 years and more will touch 225.4 million in India, 356.6 million in China, 84.8 million in the U.S., and 52 million in Brazil, by 2050.

Due to the increasing elderly population all over the world, the demand for professional aesthetic lasers will continue to grow in the years to come.

6 giugno 2023

North America ISOs Medical Device and Equipment Maintenance and Calibration Services Market Was Dominated in the U.S.

The North America ISOs medical device and equipment maintenance and calibration services market will grow at a rate of 8.9% in the years to come, to reach USD 3,612.9 million by 2030, as stated by a market research institution, P&S Intelligence.

The key factors responsible for the industry growth are progressions in the medical device sector, increase in consciousness regarding preventive medical equipment maintenance, and strict regulatory environment.

The patient monitoring and electromedical category will grow the fastest in the years to come. This has a lot to do with the high incidence of chronic ailments, such as cardiac and respiratory, increasing aging population, and growing number of ICU beds.

The U.S. had a larger share in the North America ISOs medical device and equipment maintenance and calibration services market, and the nation will continue the same way in the years to come. This is mostly because of the occurrence of a large count of hospitals and established players and rise in tech progressions with regards to diagnostic tests.

Medical devices can be employed in numerous applications, not being precise to just one area.

Furthermore, these services also aid in averting infections brought about by the usage of medical devices throughout surgeries.

Therefore, the importance on cleanliness in healthcare institutions is increasing, with a number of prestigious administrations delivering guidance for improving cleanliness and averting infections.

For example, the WHO has given guidelines for hospital hygiene, emphasizing equipment maintenance for infection control.

The incidence of a strict regulatory framework makes medical paraphernalia maintenance a required prerequisite for end users in North America.

For instance, the U.S. CMS regulations and other accreditation necessities TJC, HFAP, and DNV, along with guidelines by OEMs and the USFDA, necessitate compliance with regards to equipment maintenance amongst hospitals.

It is because of the advancements in medical industry, the demand for medical device and equipment maintenance and calibration services in North America will be on the rise in the years to come.

6 giugno 2023

Medical Cartridges Industry Will Grow Fastest in the Asia-Pacific Region

The medical cartridges market will grow at a rate of 6.4% in the years to come to touch a value of USD 1,691.1 million by 2030. The factors accountable for the growth of the industry are growing pharma sector and increasing requirement for injectable pharma products.

Also, the surging elderly population and increasing occurrence of chronic and acute diseases will boost the requirement for medical cartridges all over the world.

On the basis of material type, the industry is categorized into plastic and glass. The glass category had larger share in the past, as stated by a market expert at P&S Intelligence.

Europe had the largest share in the medical cartridges market in the recent past. This is mostly credited to the increasing occurrence diabetes.

Also, deskbound lifestyle of people in the region is the main reason for obesity. For example, as per the IDF Diabetes Atlas Ninth Edition, about 59 million adults, who were aged 20–79 years suffered from diabetes in 2019.

Alternatively, APAC will grow the fastest in the years to come, because of the growing elderly population in the region, increasing incidence of diabetes, and expanding healthcare spending.

The growing pharma sector has an important role to play in the growth of the industry. The industry manufactures biologics and biosimilar drugs for managing a number of chronic diseases, for example diabetes, cancer, and rheumatoid arthritis. Some biopharma products are advanced and manufactured in the form of injectable therapeutic agents, administered through cartridges, vials, and prefilled syringes.

It is because of the aging elderly population around the world, and the developing pharma industry, the demand for medical cartridges will continue to grow in the years to come, globally.

5 giugno 2023

Lip Cold Sore Treatment Industry Was Dominated by Creams

The lip cold sore treatment market had a revenue in China, South Korea, Taiwan, Hong Kong, and SEA grow at a rate of 6.7% in the years to come to reach USD 85,265.1 Thousand by 2030 as mentioned in one of its reports by a market research institution, P&S Intelligence.

The important factors accountable for the industry growth include the thriving modes of transmission of HSV, growing incidence of cold sores, and progressions in treatments with the increasing count of product launches.

Cream dominated the industry, on the basis of product type. Also, the category will retain its position in the years to come as a result of the fact that creams is good for healing the sores fast and decrease itching, tingling, pain, and burning.

China had the largest contribution in the industry. This will also grow the fastest in the years to come. This is because of the growing incidence of HSV-1 infection amongst the rural people in the nation, presence of key industry players, and increasing consciousness of the disease.

As per a study directed by the IDEG at WCM-Q, HSV-1 is majorly transmitted through mouth to-mouth contact, therefore bringing about an infection on or around the mouth, which is recognized as oral herpes.

Furthermore, asymptomatic and symptomatic viral shedding are highly common, which has allowed the virus to be transmitted additionally, at a high pace.

The market is fragmented in nature, and the major players are involved in a number of mergers and acquisitions.

It is because of the growing prevalence of cold sores, the demand for lip cold sore treatments will continue to grow in the years to come.

5 giugno 2023

Growth of the Gene Therapy Market in Asia-Pacific

The Asia-Pacific gene therapy market will power at a rate of 36.8% in the years to come to reach USD 6,931.5 million by 2030, as stated by a market research institution, P&S Intelligence.

The factors responsible for market growth are the growing gene therapy development activities, surging chronic diseases burden, and growing count of clinical trials with positive results.

The adenovirus category will grow the fastest growth in the years to come, on the basis of vector type. This will mostly be as a result of the high level of expressions and high transduction competence of these kind of vectors.

The carcinoma category led the industry. As per the GLOBOCAN, 2.3 million cases of cancer were stated in Southeast Asia and 1.4 million people lost their lives as a result of it in 2020.

China had the highest revenue in the industry and it will maintain its position in the future. This has a lot to do with the increasing count of strategic expansions amongst main companies and snowballing occurrence of cancer and rare ailments.

The increasing participation of private and public research institutions in gene therapy research is responsible for powering the growth of the industry in APAC. As a result of the rapid tech progressions over decades, the expansion of gene therapies has recuperated momentous interest.

This procedure is being proficient by the optimization of vectors, for example lentiviruses and retroviruses, by the initiation of novel procedures, for example induced pluripotent stem cells, in combination with the prevailing models of gene editing and even by trials in germ cells.

It is because of the positive clinical trials results, the requirement for gene therapy in the APAC region will continue to increase in the years to come.

2 giugno 2023

Interventional Vascular Consumables Industry Growth and Demand Forecast to 2030

The total value of the global interventional vascular consumables market was USD 3,929.2 million in 2021, and it will rise at a growth rate of above 3.8% shortly, reaching USD 5,501.7 million by 2030, according to P&S Intelligence.

This growth can be attributed to the growing count of CVD cases throughout the world is boosting the need for interventional vascular procedures. For example, as per the WHO, approximately 17.9 million individuals expire of CVDs per annum, representing 32.0% of all worldwide demises.

In 2021, the consumables utilized in coronary interventional events generated the highest revenue share of approximately 80%. The growing occurrence of coronary heart illness, related to the growing elderly populace, is directing to the rising demand for the consumables utilized during coronary procedures.

In 2021, North America dominated the interventional vascular consumables market with the largest share, 35.2%. The supremacy of the region in the industry is majorly credited to the increasing healthcare investments, growing count of cases of chronic illnesses, and increasing elderly populace.

As per a report in the U.S., issued by the Rural Health Information Hub, 46 million individuals were aged 65 and more in 2020, and this count is set to surge to nearly 90 million by 2050. The thriving elderly populace leads to the increasing occurrence of chronic illnesses, therefore causing a high requirement for interventional vascular consumables in the continent.

Interventional procedures are favored by elder patients as such procedures have a lesser danger of complications and are inexpensive. Furthermore, they are chosen as with age, patients’ capability to heal the marks of the operation might reduce.

Hence, the growing count of CVD cases throughout the world is boosting the need for interventional vascular procedures.